C
PHAT icon

Covestor’s Phathom Pharmaceuticals PHAT Stock Holding History

Covestor’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
29
+21
+263% +$240 ﹤0.01% 2759
2026
Q1 		$0 Sell
8
-8
-50% -$101 ﹤0.01% 2656
2025
Q4 		$0 Hold
16
– – ﹤0.01% 2627
2025
Q3 		$0 Hold
16
– – ﹤0.01% 2643
2025
Q2 		$0 Buy
16
+9
+129% +$50 ﹤0.01% 2620
2025
Q1 		$0 Hold
7
– – ﹤0.01% 2602
2024
Q4 		$0 Buy
+7
New +$87 ﹤0.01% 2611

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Covestor's PHAT Position: Q2 2026 in Review

Covestor increased its Phathom Pharmaceuticals (PHAT) stake by 263% in Q2 2026, buying an estimated $240 and bringing the position to 29 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2759.

Covestor first reported a position in PHAT in Q4 2024 and has held it in 7 quarters since. 162 funds tracked by Wall St. Rank hold PHAT as of Q2 2026.

  • Covestor held 29 shares of Phathom Pharmaceuticals worth $0 as of Q2 2026.
  • Covestor bought 21 Phathom Pharmaceuticals shares in Q2 2026, an estimated $240.
  • Phathom Pharmaceuticals made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2759 holding.
  • Covestor first reported a position in Phathom Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 162 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.